| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.9M | +78.1% | +568.1% |
| Cost of Revenue | $3.9M | +35.0% | +608.7% |
| Gross Profit | $1.1M | +1444.2% | +455.5% |
| R&D Expense | $146K | -24.8% | -31.8% |
| SG&A Expense | $611K | -7.4% | +4.0% |
| Interest Expense | $665K | +8212.5% | — |
| Net Income | $65.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.5M | +601.8% | +1662.9% |
| Current Assets | $298.3M | +637.5% | +1028.9% |
| Total Assets | $298.9M | +632.3% | +1026.3% |
| Current Liabilities | $62.4M | +1162.6% | +4562.5% |
| Total Liabilities | $73.5M | +654.2% | — |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.0M | — | — |
| Capital Expenditures | $8K | — | — |
| Investing Cash Flow | -$196.8M | — | — |
| Financing Cash Flow | $205.4M | — | — |
| Free Cash Flow | -$6.0M | — | — |
| +1589.8% |
| +825.6% |
| EPS (Basic) | $1.48 | +722.2% | +364.3% |
| EPS (Diluted) | $1.30 | +828.6% | +332.1% |
| $225.4M |
| +625.5% |
| +794.6% |